Emphysema Phenotypes and Lung Volume Reduction

Prepared and reviewed by the PrepElephant Academic Review Team

First published 14 Oct 2026 · Spot an error?

Reference basis: Harrison's Principles of Internal Medicine; Murray and Nadel's Textbook of Respiratory Medicine

On this page

Direct answer
What you must remember
Classifying emphysema by distribution and cause
Where the exam tries to catch you
Frequently asked questions
Related topics

Direct answer

Emphysema phenotypes are defined by the pattern of alveolar destruction. Centrilobular disease, the commonest form, affects the respiratory bronchioles and is typical of smokers, while panacinar disease destroys the whole acinus and is characteristic of alpha-1 antitrypsin deficiency. Hyperinflation flattens the diaphragm and limits exercise, and lung volume reduction surgery or endobronchial valves are considered only for carefully selected patients with severe upper-lobe disease.

What you must remember

Centrilobular: upper-zone predominant destruction of the centre of the lobule, strongly linked to cigarette smoking.
Panacinar: lower-zone predominant destruction of the whole acinus, classically seen with alpha-1 antitrypsin deficiency, especially the ZZ genotype.
Paraseptal: subpleural bullae along the septa, which can rupture and cause spontaneous pneumothorax.
Hyperinflation: a flattened diaphragm, reduced elastic recoil and raised residual volume, which causes dynamic hyperinflation during exercise.
Heterogeneity: the benefit of volume reduction depends on heterogeneous, upper-lobe predominant disease; endobronchial valves additionally need absent collateral ventilation between the target lobe and the rest of the lung.
Dangerous targets: homogeneous emphysema with a very low DLCO carried high surgical mortality in trials and is a poor candidate.
Core measures: smoking cessation, long-term oxygen when criteria are met and pulmonary rehabilitation remain the basis of care.

Classifying emphysema by distribution and cause

The phenotype determines the prognosis, the therapy and whether volume reduction is feasible at all. The table compares the four patterns examiners most often ask about.

Phenotype	Distribution	Usual cause	Clinical point
Centrilobular	Upper zones, centre of lobule	Cigarette smoking	Most common, patchy and heterogeneous
Panacinar	Lower zones, whole acinus	Alpha-1 antitrypsin deficiency	Basal disease, early breathlessness
Paraseptal	Subpleural, along septa	Ageing and smoking	Bullae can rupture and cause pneumothorax
Irregular	Random, scarred	Inflammation and scarring	Usually incidental, of minor significance

Phenotype is identified on high-resolution CT and mapped to the clinical story. Heterogeneous upper-lobe disease is the setting in which surgical or valve options can help, whereas diffuse disease usually is not. Patients with severe disease but no clear target are managed medically.

Assessment combines spirometry showing airflow obstruction with a reduced transfer factor, a six-minute walk test and a CT that maps the distribution of destruction. Only then is the candidate placed in the right group for medical therapy, valves or surgery, and the choice is confirmed at a multidisciplinary meeting.

Where the exam tries to catch you

Students often mistake hyperinflation for improvement, or apply volume reduction to patients who will not benefit.

Trap: operating on homogeneous emphysema with a very low DLCO for volume reduction Correct: this group had high surgical mortality in trials, so such patients are poor candidates.
Trap: assuming upper-lobe disease suits any valve Correct: valves need a target lobe without collateral ventilation, usually suggested by a complete fissure on CT.
Trap: treating panacinar emphysema with bronchodilators alone in ZZ patients Correct: alpha-1 antitrypsin augmentation is considered in selected patients, alongside smoking cessation.
Trap: interpreting hyperinflation as improvement Correct: a flattened diaphragm reduces inspiratory reserve and limits exercise, and that mechanism is what volume reduction targets.

Frequently asked questions

Which emphysema phenotype is typical of smokers?

Centrilobular emphysema is the phenotype typical of smokers, with destruction of the respiratory bronchioles and predominantly upper-zone involvement. It is the commonest form of emphysema overall.

Which emphysema phenotype is linked to alpha-1 antitrypsin deficiency?

Panacinar emphysema is linked to alpha-1 antitrypsin deficiency, especially the ZZ genotype, and it causes predominantly lower-zone disease. Smokers with this deficiency develop it earlier and more severely.

Which patients benefit from lung volume reduction surgery?

Patients with heterogeneous, upper-lobe predominant emphysema and low exercise capacity after rehabilitation may benefit from lung volume reduction surgery. Homogeneous disease with a very low DLCO carries a high risk, so it is generally avoided.

How do endobronchial valves differ from lung volume reduction surgery?

Endobronchial valves are placed bronchoscopically to block airflow into a target lobe, whereas surgery removes diseased lung tissue. Valves need a target lobe without collateral ventilation, while surgery depends on heterogeneity and fitness for an operation.

What is dynamic hyperinflation and why does it limit exercise?

Dynamic hyperinflation is the rise in end-expiratory lung volume during exercise because the patient cannot exhale fully in the short time available. It reduces inspiratory capacity, which limits the rise in tidal volume and causes breathlessness.